Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
Titel:
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
Auteur:
Verhoeff, Sarah R. Es, Suzanne C. van Boon, Eline Helden, Erik van Angus, Lindsay Elias, Sjoerd G. Oosting, Sjoukje F. Aarntzen, Erik H. Brouwers, Adrienne H. Kwee, Thomas C. Heskamp, Sandra Hoekstra, Otto S. Verheul, Henk Veldt, Astrid A. M. van der Vries, Elisabeth G. E. de Boerman, Otto C. Graaf, Winette T. A. van der Oyen, Wim J. G. Herpen, Carla M. L. van
Verschenen in:
European journal of nuclear medicine and molecular imaging